Company · CIK 0001590877 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
REGENXBIO Inc. · RGNX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 FForm 4 → | Sep 3, 5:30 pm EDT | Craig MalzahnChief Technology Officer | 234 | $9.32 | $2,181 | 81,960 | — | |
| Sep 1, 2026 FForm 4 → | Sep 3, 5:29 pm EDT | Mitchell ChanChief Financial Officer | 4,902 | $9.32 | $45,687 | 122,815 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.